Histopathological evidence that spermatogonia are the target cells of 2-bromopropane

Citation
M. Omura et al., Histopathological evidence that spermatogonia are the target cells of 2-bromopropane, TOX LETT, 104(1-2), 1999, pp. 19-26
Citations number
19
Categorie Soggetti
Pharmacology & Toxicology
Journal title
TOXICOLOGY LETTERS
ISSN journal
03784274 → ACNP
Volume
104
Issue
1-2
Year of publication
1999
Pages
19 - 26
Database
ISI
SICI code
0378-4274(19990111)104:1-2<19:HETSAT>2.0.ZU;2-E
Abstract
To confirm the target cell of 2-bromopropane within the testis, 1355 mg/kg of 2-bromopropane was subcutaneously injected to rats for 1-5 days and the numbers of spermatogonia and spermatocytes were examined 6 h after each las t injection. The number of stage I spermatogonia decreased after the first 2-bromopropane injection and the number of spermatogonia at the other stage s also decreased following repetitive injection. The number of these sperma togonia decreased further by the repetition of 2-bromopropane injection. In addition, the delay in mitotic division of type B spermatogonia was freque ntly observed after the fifth 2-bromopropane injection. The number of stage I pachytene spermatocytes also decreased slightly after the first 2-bromop ropane injection, although it did not decrease further following repetitive injection. Therefore, we concluded that spermatogonia are the target cells of 2-bromopropane in rats. (C) 1999 Elsevier Science Ireland Ltd. All righ ts reserved.